Prostate Cancer - Results from #18760

Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: A nested case-control study - Abstract April 8, 2015

Combination of multi-parametric magnetic resonance imaging (mp-MRI) and transperineal template-guided mapping biopsy (TTMB) of the prostate to identify candidates for hemi-ablative focal therapy - Abstract April 8, 2015

The role of radiotherapy in node-positive prostate cancer - Abstract April 8, 2015

The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI - Abstract April 8, 2015

Fractionated changes in prostate cancer radiotherapy using cone-beam computed tomography - Abstract April 8, 2015

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: A propensity score-matched analysis - Abstract April 7, 2015

The natural course of pT2 prostate cancer with positive surgical margin: Predicting biochemical recurrence - Abstract April 7, 2015

Is primary tumor detectable in prostatic carcinoma at routine contrast-enhanced CT? - Abstract April 7, 2015

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Expanded access in North America - Abstract April 7, 2015

Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy - Abstract April 6, 2015

Clinical and pathological features of metastatic adenocarcinoma of the prostate to the ileum - Abstract April 6, 2015

Systemic therapy for the treatment of hormone-sensitive metastatic prostate cancer: From intermittent androgen deprivation therapy to chemotherapy - Abstract April 6, 2015

Management of metastatic hormone-sensitive prostate cancer - Abstract April 6, 2015

Self-reported health status predicts other-cause mortality in men with localized prostate cancer: Results from the Prostate Cancer Outcomes study - Abstract April 6, 2015

Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer - Abstract April 6, 2015

Continuous monitoring and intrafraction target position correction during treatment improves target coverage for patients undergoing SBRT prostate therapy - Abstract April 6, 2015

From whole gland to hemigland to ultra-focal high-dose rate prostate brachytherapy: A dosimetric analysis - Abstract April 6, 2015

Incidence and predictors of upgrading and upstaging among 10,000 contemporary patients with low-risk prostate cancer - Abstract April 6, 2015

The role of intermittent androgen deprivation therapy in the management of biochemically recurrent or metastatic prostate cancer - Abstract April 4, 2015

Biomarkers in metastatic castration-resistant prostate cancer - Abstract April 3, 2015

Page 939 of 1457